|Videos|June 11, 2021

Pharmacist Medication Insights: Dupilumab for Atopic Dermatitis, Asthma

Dupilumab is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins.

Dupilumab is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins. Data from dupilumab clinical trials have shown that IL-4 and IL-13 are key drivers of the type 2 inflammation that plays a major role in atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Webinar Registration

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

October 9, 2025 | 1:00 & 8:00 PM EDT

Virtual Event

Infectious Disease Day of Education 2025

October 9, 2025 | 10:00 AM EDT – 6:00 PM EDT

Webinar Registration

Clinical Presentation of Hyperglycemia With PI3K and AKT Inhibitors

October 14, 2025 | 1:00 PM & 8:00 PM ET

Panel Discussion Registration

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

October 15, 2025 | 7:00 PM EDT

Virtual Conference

Directions in Oncology Pharmacy® 2025: West Coast

Thursday, October 16, 2025

Webinar Registration

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

October 21, 2025 | 1:00 PM & 8:00 PM ET

Pharmacist Medication Insights: Dupilumab for Atopic Dermatitis, Asthma

Newsletter

Related Content

Clinical and Public Health Implications of Recent H5N1 Poultry Outbreaks

New Frontiers in Hypertension Care: Insights from the Cardia-3 and Bax Hypertension Trials

FDA Grants Fast Track Designation to BMS-986446 for Treatment of Early Alzheimer Disease

Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment

From Policy to Practice: How the ACC Legislative Conference Advances Cardiovascular Care

Latest CME

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Infectious Disease Day of Education 2025

Clinical Presentation of Hyperglycemia With PI3K and AKT Inhibitors

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Directions in Oncology Pharmacy® 2025: West Coast

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

ASCP 2025 Satellite Symposia

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

AMCP Nexus 2025

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine Uptake and Optimally Utilize Available Vaccines

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer

Asembia Specialty Pharmacy Day of Education 2025

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Addressing Gaps in Care for Hyperkalemia With Novel Oral Potassium Binding Agents

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Directions in Oncology Pharmacy® 2025: Northeast

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

ASHP Midyear 2025

Overview and Burden of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

The Impact and Role of Pharmacists in the Management of Specialty Therapies

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-System Pharmacists

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

The Role of the Pharmacist in the Management of Hyperlipidemia

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis (Pharmacy Technician Credit)

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Beyond the Spots: Management of Measles

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden